» Articles » PMID: 39334418

Association Between Pre-diagnosis and Post-diagnosis Alternate Mediterranean Diet and Ovarian Cancer Survival: Evidence from a Prospective Cohort Study

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2024 Sep 28
PMID 39334418
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is currently a lack of comprehensive evidence regarding the correlation between Alternate Mediterranean Diet (AMED) and the survival of patients with ovarian cancer (OC). This prospective cohort study first assessed the association of AMED, not only pre-diagnosis and post-diagnosis but also the change from pre-diagnosis to post-diagnosis with OC survival.

Methods: A total of 560 OC patients were included in the study, and their dietary intake was assessed using a reliable 111-item food frequency questionnaire. The overall survival (OS) of the patients was monitored through active follow-up and review of medical records until February 16th, 2023. Cox proportional hazard regression models were utilized to compute the hazard ratios (HRs) and their corresponding 95% confidence intervals (CIs).

Results: Out of the total 560 patients with OC, 211 (37.68%) succumbed during a median follow-up period of 44.40 months (interquartile range: 26.97-61.37). Comparative analysis indicated a significant association between the highest tertiles of pre-diagnosis (HR = 0.59; 95% CI 0.38-0.90; P < 0.05) and post-diagnosis (HR = 0.61; 95% CI 0.41-0.91; P < 0.05) AMED intake and improved OS as opposed to the lowest tertile. Additionally, a significant linear trend was observed for AMED and OC survival. Notably, decreased intake (more than 5% change) and significantly increased intake (more than 15% change) of AMED from pre-diagnosis to post-diagnosis were linked to worse and better OS, respectively, when compared to the stable intake group (change within 5%). Furthermore, patients displaying consistently higher AMED intake both before and after diagnosis experienced enhanced OS in comparison to those with consistently low AMED intake (HR = 0.47; 95% CI 0.31-0.70).

Conclusion: High pre-diagnosis and post-diagnosis AMED was associated with an improved OS in patients with OC, suggesting that maintaining a consistently high intake of AMED could potentially benefit the prognosis of OC.

Citing Articles

Pre- and post-diagnosis dietary patterns and overall survival in patients with epithelial ovarian cancer: a prospective cohort study.

Qin Y, Chen X, Cao F, Liu J, Wu L, Liu F BMC Cancer. 2025; 25(1):363.

PMID: 40016667 PMC: 11869420. DOI: 10.1186/s12885-025-13610-5.


Disease-free survival of 15 years after primary surgery in a patient with advanced high-grade serous ovarian cancer: a case report and literature review.

Shi Y, Zhu S, Shan J, Xu Y Front Oncol. 2025; 15:1468196.

PMID: 39931084 PMC: 11807797. DOI: 10.3389/fonc.2025.1468196.

References
1.
Achon M, Alonso-Aperte E, Reyes L, Ubeda N, Varela-Moreiras G . High-dose folic acid supplementation in rats: effects on gestation and the methionine cycle. Br J Nutr. 2000; 83(2):177-83. View

2.
Sasamoto N, Wang T, Townsend M, Eliassen A, Tabung F, Giovannucci E . Pre-diagnosis and post-diagnosis dietary patterns and survival in women with ovarian cancer. Br J Cancer. 2022; 127(6):1097-1105. PMC: 9470575. DOI: 10.1038/s41416-022-01901-8. View

3.
Fung T, McCullough M, Newby P, Manson J, Meigs J, Rifai N . Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2005; 82(1):163-73. DOI: 10.1093/ajcn.82.1.163. View

4.
Amir E, Seruga B, Kwong R, Tannock I, Ocana A . Poor correlation between progression-free and overall survival in modern clinical trials: are composite endpoints the answer?. Eur J Cancer. 2011; 48(3):385-8. DOI: 10.1016/j.ejca.2011.10.028. View

5.
Haneuse S, VanderWeele T, Arterburn D . Using the E-Value to Assess the Potential Effect of Unmeasured Confounding in Observational Studies. JAMA. 2019; 321(6):602-603. DOI: 10.1001/jama.2018.21554. View